INTERVIEW: Actavis CEO Saunders staying put as Allergan deal nears close
This article was originally published in Scrip
Executive Summary
Actavis CEO Brent Saunders has been the head of three different companies in less than two years, but with the $66bn acquisition of Allergan about to close any day now, he told Scrip that he's found the place where he plans to retire.